Literature DB >> 23188134

Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: a methodological review.

Susanne Singer1, Juan Ignacio Arraras, Wei-Chu Chie, Sheila E Fisher, Razvan Galalae, Eva Hammerlid, Ourania Nicolatou-Galitis, Claudia Schmalz, Irma Verdonck-de Leeuw, Eva Gamper, Judith Keszte, Dirk Hofmeister.   

Abstract

PURPOSE: The EORTC QLQ-H&N35 (H&N35) is widely used to measure quality of life in head and neck cancer patients. The aims of this study were to obtain insight into a) the languages in which the H&N35 has been used and the psychometric properties in those languages, b) the study designs, and c) its acceptance by patients and investigators.
METHODS: A systematic literature review was performed searching for all original papers that had used at least one item of the H&N35. Identified papers were read and the information about methodological issues abstracted statistically analysed.
RESULTS: A total of 136 papers were identified. The H&N35 was administered in 19 different languages in 27 countries. The study design was cross-sectional in the majority of studies (53 %), prospective cohort studies (31 %), phase-II-trials (7 %), phase-III-trials (6 %) and case-control studies (1 %). The scales with the highest percentages of missing values were Sexuality (11.5 %) and Speech (7 %). The median Cronbach's alpha of the multi-item scales ranged from 0.61 (Senses) to 0.93 (Sexuality). Construct validity was rarely investigated. On average, 12 scales (range 0-18) of the instrument were used by the investigators. The scale most often used was swallowing (in 85 % of studies) and least often used was Weight Gain (39 %).
CONCLUSION: The H&N35 is widely used throughout the world, mainly in observational studies, and has demonstrated robust psychometric features in different languages. However, some methodological problems reported imply that the instrument can be improved in some areas.

Entities:  

Mesh:

Year:  2012        PMID: 23188134     DOI: 10.1007/s11136-012-0325-1

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  81 in total

1.  Impact of intraoral soft-tissue reconstruction on the development of quality of life after ablative surgery in patients with oral cancer.

Authors:  Henning Schliephake; Maximiliam U Jamil
Journal:  Plast Reconstr Surg       Date:  2002-02       Impact factor: 4.730

2.  [Significance of support groups for patients after total laryngectomy for laryngeal carcinoma].

Authors:  Maciej Gryczyński; Anna Pajor; Elzbieta A Ciechomska; Katarzyna Starska
Journal:  Otolaryngol Pol       Date:  2003

3.  The Groningen Radiotherapy-Induced Xerostomia questionnaire: development and validation of a new questionnaire.

Authors:  Ivo Beetz; Fred R Burlage; Henk P Bijl; Olga Hoegen-Chouvalova; Miranda E M C Christianen; Arjan Vissink; Bernard F A M van der Laan; Geertruida H de Bock; Johannes A Langendijk
Journal:  Radiother Oncol       Date:  2010-06-10       Impact factor: 6.280

4.  [Quality of life after treatment of laryngeal carcinoma: surgery versus radiotherapy].

Authors:  A Schneider; M Guidicelli; S J Stöckli
Journal:  Schweiz Med Wochenschr Suppl       Date:  2000

5.  [Subcranial resection of malignant tumors infiltrating the anterior skull base].

Authors:  H Riechelmann; D Meling; P Messer; H P Richter; G Rettinger; G Antoniadis
Journal:  Laryngorhinootologie       Date:  2006-02-02       Impact factor: 1.057

6.  Organ function and quality of life after transoral laser microsurgery and adjuvant radiotherapy for locally advanced laryngeal cancer.

Authors:  Arno Olthoff; Andreas Ewen; Hendrik Andreas Wolff; Robert Michael Hermann; Hilke Vorwerk; Andrea Hille; Ralph Rödel; Clemens F Hess; Wolfgang Steiner; Olivier Pradier; Hans Christiansen
Journal:  Strahlenther Onkol       Date:  2009-05-15       Impact factor: 3.621

7.  Health-related quality of life five years after diagnosis of laryngeal carcinoma.

Authors:  Mats Nordgren; Helmut Abendstein; Magnus Jannert; Morten Boysen; Marianne Ahlner-Elmqvist; Ewa Silander; Kristin Bjordal; Eva Hammerlid
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-08-01       Impact factor: 7.038

8.  Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group.

Authors:  K Bjordal; M Ahlner-Elmqvist; E Tollesson; A B Jensen; D Razavi; E J Maher; S Kaasa
Journal:  Acta Oncol       Date:  1994       Impact factor: 4.089

9.  First-year quality of life assessment of an intra-arterial (RADPLAT) versus intravenous chemoradiation phase III trial.

Authors:  Annemieke H Ackerstaff; Alfons J M Balm; Coen R N Rasch; Jan Paul de Boer; Ruud Wiggenraad; Derk H F Rietveld; R Theo Gregor; Robert Kröger; Frans J M Hilgers
Journal:  Head Neck       Date:  2009-01       Impact factor: 3.147

10.  Differential item functioning (DIF) in the EORTC QLQ-C30: a comparison of baseline, on-treatment and off-treatment data.

Authors:  Neil W Scott; Peter M Fayers; Neil K Aaronson; Andrew Bottomley; Alexander de Graeff; Mogens Groenvold; Chad Gundy; Michael Koller; Morten A Petersen; Mirjam A G Sprangers
Journal:  Qual Life Res       Date:  2009-02-27       Impact factor: 4.147

View more
  26 in total

1.  Socioeconomic status and quality of life in patients with locally advanced head and neck cancer.

Authors:  S Tribius; M S Meyer; C Pflug; H Hanken; C-J Busch; A Krüll; C Petersen; C Bergelt
Journal:  Strahlenther Onkol       Date:  2018-05-07       Impact factor: 3.621

Review 2.  Revisiting the dose constraints for head and neck OARs in the current era of IMRT.

Authors:  N Patrik Brodin; Wolfgang A Tomé
Journal:  Oral Oncol       Date:  2018-09-08       Impact factor: 5.337

3.  Parotid sparing and quality of life in long-term survivors of locally advanced head and neck cancer after intensity-modulated radiation therapy.

Authors:  Silke Tribius; Sven Haladyn; Henning Hanken; Chia-Jung Busch; Andreas Krüll; Cordula Petersen; Corinna Bergelt
Journal:  Strahlenther Onkol       Date:  2020-12-30       Impact factor: 3.621

Review 4.  The humanistic burden of head and neck cancer: a systematic literature review.

Authors:  Erika Wissinger; Ingolf Griebsch; Juliane Lungershausen; Michael Byrnes; Karin Travers; Chris L Pashos
Journal:  Pharmacoeconomics       Date:  2014-12       Impact factor: 4.981

5.  Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer: Results of a prospective study.

Authors:  Silke Tribius; Marieclaire Raguse; Christian Voigt; Adrian Münscher; Alexander Gröbe; Cordula Petersen; Andreas Krüll; Corinna Bergelt; Susanne Singer
Journal:  Strahlenther Onkol       Date:  2015-03-08       Impact factor: 3.621

6.  Predictors of changes in quality of life in head and neck cancer patients: a prospective study over a 6-month period.

Authors:  Julia Roick; Helge Danker; Andreas Dietz; Kirsten Papsdorf; Susanne Singer
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-10-23       Impact factor: 2.503

7.  Feasibility and impact of a dedicated multidisciplinary rehabilitation program on health-related quality of life in advanced head and neck cancer patients.

Authors:  Ellen Passchier; Martijn M Stuiver; Lisette van der Molen; Stefanie I C Kerkhof; Michiel W M van den Brekel; Frans J M Hilgers
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-30       Impact factor: 2.503

8.  Randomized Clinical Trial on Reduction of Radiotherapy Dose to the Elective Neck in Head and Neck Squamous Cell Carcinoma: Results on the Quality of Life.

Authors:  S Deschuymer; D Nevens; F Duprez; J F Daisne; M Voordeckers; W De Neve; S Nuyts
Journal:  Qual Life Res       Date:  2020-09-13       Impact factor: 4.147

9.  Medical marijuana use in head and neck squamous cell carcinoma patients treated with radiotherapy.

Authors:  David A Elliott; Nima Nabavizadeh; Jeanna L Romer; Yiyi Chen; John M Holland
Journal:  Support Care Cancer       Date:  2016-03-23       Impact factor: 3.603

10.  Treatment of Medication-Related Osteonecrosis of the Jaw and its Impact on a Patient's Quality of Life: A Single-Center, 10-Year Experience from Southern Italy.

Authors:  Giacomo Oteri; Gianluca Trifirò; Matteo Peditto; Loredana Lo Presti; Ilaria Marcianò; Francesco Giorgianni; Janet Sultana; Antonia Marcianò
Journal:  Drug Saf       Date:  2018-01       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.